β-Amyloid Treatment Sensitizes Mice to Amphetamine-Induced Locomotion but Reduces Response to Caffeine
Authors:
- Oscar P. Dall’iGnaODOscar P. Dall’iGna
- Anselmo HoffmannAHAnselmo Hoffmann
- Adriana L. da SilvaASAdriana L. da Silva
- Diogo O. SouzaDSDiogo O. Souza
- Diogo R. LaraDLDiogo R. Lara
- 1 April 2004
- journal article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 1 (1) , 38-43
Abstract
Backgroud: Psychosis frequently occurs in Alzheimer’s disease (AD), being associated with more severe cognitive decline, but the underlying mechanisms are unknown. Objective: To investigate the effect of centrally administered β-amyloid peptide, a model for AD, in the locomotor response to amphetamine, caffeine and MK-801, which are psychoactive drugs related to neurochemical changes occurring in psychosis. Methods: Mice were intracerebroventricularly injected with β-amyloid (25–35), and after 1 week they were tested in the passive avoidance, spontaneous alternation and locomotor tasks. Results: Besides impaired performance in inhibitory avoidance and spontaneous alternation tasks, β-amyloid-treated mice showed increased spontaneous locomotion, augmented response to amphetamine (1.5 mg/kg), blunted response to caffeine (30 mg/kg) and no difference in MK-801 (0.25 mg/kg)-induced locomotor activation when compared to its respective control. Conclusion: These results are compatible with the hypothesis that β-amyloid peptide may predispose to psychotic symptoms of AD by increasing sensitivity of the dopaminergic system, possibly related to a decreased adenosinergic inhibitory tone.Keywords
This publication has 22 references indexed in Scilit:
- Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2ReceptorsJournal of Biological Chemistry, 2002
- Memory deficits and increased emotionality induced by β-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampusJournal of Neural Transmission, 2001
- Does Fast Dissociation From the Dopamine D2Receptor Explain the Action of Atypical Antipsychotics?: A New HypothesisAmerican Journal of Psychiatry, 2001
- Neurobehavioral development, adult openfield exploration and swimming navigation learning in mice with a modified β-amyloid precursor protein geneBehavioural Brain Research, 1998
- Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal gangliaTrends in Neurosciences, 1997
- The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: An animal analogue of schizophreniaBehavioural Brain Research, 1993
- Treatment of schizophrenia: A clinical and preclinical evaluation of neuroleptic drugsPharmacology & Therapeutics, 1993
- In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragmentNeurobiology of Aging, 1992
- Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the ratBrain Research, 1992
- Patterns of locomotor and stereotypic behavior during continuous amphetamine administration in ratsPharmacology Biochemistry and Behavior, 1988